EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE

Skip to content

Search:

About us
Contact us

Superior MPE

Myeloma Patients Europe

Myeloma and AL Amyloidosis
- Multiple Myeloma
- About AL amyloidosis
What we do
Educational resources
European Myeloma Day
News

Facebook page opens in new window Twitter page opens in new window YouTube page opens in new window Linkedin page opens in new window

EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE

About MPE
Contact us
Myeloma and AL Amyloidosis
- About myeloma
- About AL amyloidosis
What we do
Educational resources
News
European Myeloma Day

Involvement in MPE activities: registration for interested individuals

You are here:

Home
Involvement in MPE activities: registration…

Name*
First Last
Email*
Country*
I am (check all that apply)*
- Myeloma patient
- AL amyloidosis patient
- Myeloma carer
- AL amyloidosis carer
- Patient advocate
- Healthcare Professional
- Other
*
Please tell us more below – if you have specific background or skills in areas such as medical writing, graphic design or other ways in which you’d like to help MPE, please tell us more about this!
Interest in MPE activities
Areas of interest (check all that apply)*
- Surveys around treatments, trials or around patient preferences
- Reviewing materials designed for patients
- Developing materials designed for patients
- Workgroups, tasks or activities relating to Patient Engagement
- Workgroup, tasks or activities relating to Clinical Research & Development
- Workgroup, tasks or activities relating to Access to clinical trials and treatment
- Myeloma Community Advisory Board
- Other Patient Councils, Advisory Boards or Panels
- Patient representation in EMA drug approval processes
- MPE Advocate Development Programme
- MPE workshops, events and conferences
- Other ways – I have other skills I would like to contribute!
*
Please, please tell us more below
Do you have any prior experience in these areas?
Please indicate all that apply (experience is absolutely not essential!)
- Surveys around treatments, trials or around patient preferences
- Reviewing materials designed for patients
- Developing materials designed for patients
- Workgroups, tasks or activities relating to Patient Engagement
- Workgroup, tasks or activities relating to Clinical Research & Development
- Workgroup, tasks or activities relating to Access to clinical trials and treatment
- Myeloma Community Advisory Board
- Other Patient Councils, Advisory Boards or Panels
- Patient representation in EMA drug approval processes
- MPE Advocate Development Programme
- MPE workshops, events and conferences
Subscribe to our newsletter to stay informed on MPE news and activities?*
- Yes. Sign me up!
- No, not right now
Click here to subscribe to our newsletter
*
- I have read and I accept the privacy policy
Our privacy policy tells you how we manage your submitted data.
CAPTCHA

Latest news

EMA recommends expansion of melphalan flufenamide (Pepaxti®) marketing authorisation
September 18, 2023
Job Offer – Access and Policy Manager
September 12, 2023
European Commission approves talquetamab for the treatment of relapsed and refractory myeloma
August 22, 2023
FDA approves elranatamab (ELREXFIO™) for relapsed or refractory myeloma
August 21, 2023

Search for:

Myeloma Patients Europe AISBL

Avenue Louise 143/4, 1050 Brussels

Belgium

© Myeloma Patients Europe 2023

Contact
About us
Privacy Policy
Terms and conditions
Cookies Policy

I am a*
- Patient
- Patient advocate
- Caregiver
- Doctor
Comments
This field is for validation purposes and should be left unchanged.